(Q37492480)

20 August 2017

1 reference

title

Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics (English)

1 reference

inflammatory bowel diseases

20 August 2017

main subject

0 references

0 references

0 references

Gil Y Melmed

1

1 reference

20 August 2017

publication date

1 September 2009

1 reference

Inflammatory Bowel Diseases

20 August 2017

published in

1 reference

20 August 2017

volume

15

1 reference

20 August 2017

issue

9

1 reference

20 August 2017

page(s)

1410-1416

1 reference

Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study

20 August 2017

cites work

1 reference

Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years.

21 January 2018

1 reference

The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.

21 January 2018

1 reference

Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis

21 January 2018

1 reference

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

21 January 2018

1 reference

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

21 January 2018

1 reference

Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.

21 January 2018

1 reference

Guidelines for immunizations in patients with inflammatory bowel disease

21 January 2018

1 reference

Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).

21 January 2018

1 reference

Effectiveness of influenza vaccine in the community-dwelling elderly

21 January 2018

1 reference

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

21 January 2018

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

Immune response to influenza vaccine in children with inflammatory bowel disease

21 January 2018

1 reference

Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers

21 January 2018

1 reference

Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.

21 January 2018

1 reference

Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease

21 January 2018

1 reference

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination

21 January 2018

1 reference

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

21 January 2018

1 reference

The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.

21 January 2018

1 reference

Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis

21 January 2018

1 reference

Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease.

21 January 2018

1 reference

Abnormal Pap smears in inflammatory bowel disease

21 January 2018

1 reference

Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease

21 January 2018

1 reference

Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20943

1 reference

20 August 2017

1 reference